Monday November 9 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Ebixa

Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease. Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a novel mechanism of action that targets the glutamatergic signalling in the brain.


Contact Details:
H. Lundbeck A/S Ottiliavej 9
Copenhagen
Valby
DK 2500
Denmark
Tel:45 36 30 13 11
Fax:45 36 30 19 40
Email:information@lundbeck.com
WWW:

www.ebixa.com/




Press Releases on Ebixa:

BioPortfolio Logo
Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 3rd December, 2008 Decision Resources
WALTHAM, Mass., Dec. 3 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the diagnosis
An introduction to the key CNS Disorders 1st January, 1970 Dailyupdates
An introduction to the key CNS Disorders Alzheimer's Disease: Over the last 3 years, the value of the Alzheimer's disease market has grown by an average of 19% per year. Growth has been
The CNS Market Outlook to 2009 1st January, 1970 Datamonitor
The CNS Market Outlook to 2009 The management report 'The CNS Market Outlook to 2009' provides in-depth analysis of the current growth opportunities, threats, leading players and their future

BioNews Results for Ebixa:

No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine
News-Medical.Net:  Oct 29 2009 5:33AM Matching: ebixa
Benefit Of Memantine In The Treatment Of Alzheimer's Disease Not Proven
Red Orbit:  Oct 28 2009 11:47PM Matching: ebixa
Benefit Of Memantine In The Treatment Of Alzheimer's Disease Not Proven
Science Daily:  Oct 28 2009 11:41PM Matching: ebixa
Benefit of memantine in the treatment of Alzheimer's disease not proven
EurekAlert!:  Oct 28 2009 3:26PM Matching: ebixa
Drug firm defends Nobel winner ad
The Standard:  Oct 21 2009 11:08PM Matching: ebixa
Promote your company here: BioNewsCast - Press Release Distribution

View more Ebixa news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 289 times since April 2007, the link to the organisation's website has been followed 69 times

Search for more companies in Copenhagen

Search for more companies in Valby



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ebixa

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.